139 related articles for article (PubMed ID: 36550575)
21. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
Zheng S; Fan J; Yu F; Feng B; Lou B; Zou Q; Xie G; Lin S; Wang R; Yang X; Chen W; Wang Q; Zhang D; Liu Y; Gong R; Ma Z; Lu S; Xiao Y; Gu Y; Zhang J; Yao H; Xu K; Lu X; Wei G; Zhou J; Fang Q; Cai H; Qiu Y; Sheng J; Chen Y; Liang T
BMJ; 2020 Apr; 369():m1443. PubMed ID: 32317267
[TBL] [Abstract][Full Text] [Related]
22. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.
Kumar K; Prakash AA; Gangasagara SB; Rathod SBL; Ravi K; Rangaiah A; Shankar SM; Basawarajappa SG; Bhushan S; Neeraja TG; Khandenahalli S; Swetha M; Gupta P; Sampritha UC; Prasad GNS; Jayanthi CR
Indian J Ophthalmol; 2020 Jun; 68(6):1015-1017. PubMed ID: 32461418
[TBL] [Abstract][Full Text] [Related]
23. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.
Solis M; Gallais F; Garnier-Kepka S; Lefebvre N; Benotmane I; Ludes PO; Castelain V; Meziani F; Caillard S; Collange O; Fafi-Kremer S
J Clin Virol; 2022 Mar; 148():105120. PubMed ID: 35227970
[TBL] [Abstract][Full Text] [Related]
24. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
Ikegami S; Benirschke R; Flanagan T; Tanna N; Klein T; Elue R; Debosz P; Mallek J; Wright G; Guariglia P; Kang J; Gniadek TJ
Transfusion; 2020 Dec; 60(12):2962-2968. PubMed ID: 32840002
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
[TBL] [Abstract][Full Text] [Related]
27. Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis.
Bwire GM; Majigo MV; Njiro BJ; Mawazo A
J Med Virol; 2021 Feb; 93(2):719-725. PubMed ID: 32706393
[TBL] [Abstract][Full Text] [Related]
28. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
[TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
[TBL] [Abstract][Full Text] [Related]
31. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
[TBL] [Abstract][Full Text] [Related]
32. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.
Sims JT; Poorbaugh J; Chang CY; Holzer TR; Zhang L; Engle SM; Beasley S; Doman TN; Naughton L; Higgs RE; Kallewaard N; Benschop RJ
J Transl Med; 2022 Mar; 20(1):134. PubMed ID: 35303909
[TBL] [Abstract][Full Text] [Related]
33. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
Front Immunol; 2021; 12():664619. PubMed ID: 34305895
[TBL] [Abstract][Full Text] [Related]
34. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
[TBL] [Abstract][Full Text] [Related]
36. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
[TBL] [Abstract][Full Text] [Related]
37. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
He Y; Luo J; Yang J; Song J; Wei L; Ma W
Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
[TBL] [Abstract][Full Text] [Related]
38. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
39. Virological assessment of hospitalized patients with COVID-2019.
Wölfel R; Corman VM; Guggemos W; Seilmaier M; Zange S; Müller MA; Niemeyer D; Jones TC; Vollmar P; Rothe C; Hoelscher M; Bleicker T; Brünink S; Schneider J; Ehmann R; Zwirglmaier K; Drosten C; Wendtner C
Nature; 2020 May; 581(7809):465-469. PubMed ID: 32235945
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 respiratory viral loads and association with clinical and biological features.
Biguenet A; Bouiller K; Marty-Quinternet S; Brunel AS; Chirouze C; Lepiller Q
J Med Virol; 2021 Mar; 93(3):1761-1765. PubMed ID: 32889755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
